NEW YORK, Feb. 8, 2023 /PRNewswire/ -- According to Technavio, the global ear infection treatment market size is estimated to grow by USD 3.67 billion from 2021 to 2026. The market is estimated to grow at a CAGR of 5.44% during the forecast period. Moreover, the growth momentum will accelerate. North America will account for 37% of the market's growth during the forecast period. The report provides a comprehensive analysis of growth opportunities at regional levels, new product launches, the latest trends, and the post-pandemic recovery of the global market. For more insights on market size, request a sample report
Ear infection treatment market - Five forces
The global infection treatment market is fragmented, and the five forces analysis covers–
- Bargaining power of buyers
- The threat of new entrants
- Threat of rivalry
- Bargaining power of suppliers
- Threat of substitutes
- For an interpretation of Porter's five forces model – Buy the report!
Ear infection treatment market – Customer landscape
The report includes the market's adoption lifecycle, from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Ear infection treatment market - Segmentation assessment
Segment overview
Technavio has segmented the market based on type (middle ear infections, outer ear infections, and inner ear infections).
- The middle ear infections segment will account for a significant share of the market's growth during the forecast period. The prevalence of middle ear infections is high, which is encouraging vendors to conduct extensive R&D and launch new drugs. This, in turn, can fulfill the huge unmet need in the market, which will drive market growth through this segment during the forecast period.
Geography overview
Based on geography, the global ear infection treatment market is segmented into North America, Europe, Asia, and Rest of World (ROW). The report provides actionable insights and estimates the contribution of all regions to the growth of the global ear infection treatment market.
- North America will account for 37% of the market's growth during the forecast period. The US and Canada are the key countries for the ear infection treatment market in the region. Moreover, market growth in North America will be faster than the growth of the market in Rest of World (ROW). This growth is attributed to factors such as improved treatment options, including surgical treatment and diagnostics tools.
Ear infection treatment market – Market dynamics
Key factor driving market growth
- High-risk factors for ear infections are driving the growth of the market.
- Ear infections are caused due to various risk factors, such as bacteria, viral cold or flu season, injury to the ear, and cigarette smoke.
- As per the CDC, in the US, about 40 million adults smoke cigarettes, and approximately 4.7 million middle and high school students use at least one tobacco product, including e-cigarettes.
- Influenza virus infection or secondary bacterial infection by either S. pneumoniae or Staphylococcus aureus is also a major risk factor.
- Such high-risk factors increase the chances of ear infections significantly, which, in turn, will drive the global ear infection treatment market's growth during the forecast period.
Leading trends influencing the market
- Raising funds for research on ear infections is a key trend in the market.
- Several organizations and companies provide funding and clinical assistance for research on the treatment of various ear infections.
- For instance, in September 2020, PhotoniCare received a USD 7 million award through the National Institutes of Health (NIH) Phase llb Small Business Innovation Research (SBIR) program.
- In September 2020, the NIH granted USD 2.3 million to the Northeast Ohio Medical University for research on middle ear infections.
- Such factors are expected to fuel market growth during the forecast period.
Major challenges hindering market growth
- The side effects associated with available treatments are challenging the market's growth.
- The increasing use of antibiotics, which are used for treating ear infections, leads to antibiotic resistance. As a result, resistant bacteria can grow and multiply.
- Antibiotic resistance can lead to prolonged hospital stays, high medical costs, and increased mortality.
- Moreover, eardrops and analgesics used to reduce severe ear pain can have side effects such as burning sensation, redness, irritation, dryness, scaling, severe weakness, and swelling of the ear, which can worsen the infections instead of curing them.
- These factors are expected to limit the market growth during the forecast period.
What are the key data covered in this ear infection treatment market report?
- CAGR of the market during the forecast period
- Detailed information on factors that will drive the growth of the ear infection treatment market between 2022 and 2026
- Precise estimation of the size of the ear infection treatment market and its contribution to the parent market
- Accurate predictions about upcoming trends and changes in consumer behavior
- Growth of the ear infection treatment market industry across North America, Europe, Asia, and Rest of World (ROW)
- A thorough analysis of the market's competitive landscape and detailed information about vendors
- Comprehensive analysis of factors that will challenge the growth of ear infection treatment market vendors
Gain instant access to 17,000+ market research reports.
Technavio's SUBSCRIPTION platform
Related Reports:
The middle ear implants market size is expected to increase by USD 52.44 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 8.75%. This report extensively covers segmentation by product (electromagnetic middle ear implants and piezoelectric middle ear implants), application (sensorineural hearing loss, conductive hearing loss, and mixed hearing loss), and geography (North America, Europe, Asia, and Rest of World (ROW)).
The surgical site infection control market size is expected to increase by USD 1.48 billion from 2021 to 2026. This report extensively covers surgical site infection control market segmentation by type (superficial incisional SSI, deep incisional SSI, and organ or space SSI) and geography (North America, Europe, Asia, and Rest of World (ROW)).
Ear Infection Treatment Market Scope |
|
Report Coverage |
Details |
Page number |
136 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 5.44% |
Market growth 2022-2026 |
USD 3.67 billion |
Market structure |
Fragmented |
YoY growth 2021-2022 (%) |
4.29 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 37% |
Key countries |
US, Canada, Denmark, China, and India |
Competitive landscape |
Leading vendors, market positioning of vendors, competitive strategies, and industry risks |
Key companies profiled |
Akorn Inc., Aurobindo Pharma Ltd., Biovea, Zydus Lifesciences Ltd., Fresenius SE and Co. KGaA, GlaxoSmithKline Plc, Hyland, Johnson and Johnson, Lupin Ltd., Merck and Co. Inc., Mylan NV, Novartis AG, Otonomy Inc., Perrigo Co. Plc, Sensorion, Sun Pharmaceutical Industries Ltd., Wockhardt Ltd., WraSer Pharmaceuticals, Pfizer Inc., and F. Hoffmann La Roche Ltd. |
Market dynamics |
Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Browse for Technavio's health care market reports
Table of contents
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
- Exhibit 06: Executive Summary – Chart on Incremental Growth
- Exhibit 07: Executive Summary – Data Table on Incremental Growth
- Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 09: Parent market
- Exhibit 10: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 11: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 12: Market segments
- 3.3 Market size 2021
- 3.4 Market outlook: Forecast for 2021-2026
- Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
- Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
- 4.1 Five forces summary
- Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
- 4.2 Bargaining power of buyers
- Exhibit 18: Bargaining power of buyers – Impact of key factors in 2021 and 2026
- 4.3 Bargaining power of suppliers
- Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
- 4.4 Threat of new entrants
- Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
- 4.5 Threat of substitutes
- Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
- 4.6 Threat of rivalry
- Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
- 4.7 Market condition
- Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Type
- 5.1 Market segments
- Exhibit 24: Chart on Type - Market share 2021-2026 (%)
- Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
- 5.2 Comparison by Type
- Exhibit 26: Chart on Comparison by Type
- Exhibit 27: Data Table on Comparison by Type
- 5.3 Middle ear infections - Market size and forecast 2021-2026
- Exhibit 28: Chart on Middle ear infections - Market size and forecast 2021-2026 ($ million)
- Exhibit 29: Data Table on Middle ear infections - Market size and forecast 2021-2026 ($ million)
- Exhibit 30: Chart on Middle ear infections - Year-over-year growth 2021-2026 (%)
- Exhibit 31: Data Table on Middle ear infections - Year-over-year growth 2021-2026 (%)
- 5.4 Outer ear infections - Market size and forecast 2021-2026
- Exhibit 32: Chart on Outer ear infections - Market size and forecast 2021-2026 ($ million)
- Exhibit 33: Data Table on Outer ear infections - Market size and forecast 2021-2026 ($ million)
- Exhibit 34: Chart on Outer ear infections - Year-over-year growth 2021-2026 (%)
- Exhibit 35: Data Table on Outer ear infections - Year-over-year growth 2021-2026 (%)
- 5.5 Inner ear infections - Market size and forecast 2021-2026
- Exhibit 36: Chart on Inner ear infections - Market size and forecast 2021-2026 ($ million)
- Exhibit 37: Data Table on Inner ear infections - Market size and forecast 2021-2026 ($ million)
- Exhibit 38: Chart on Inner ear infections - Year-over-year growth 2021-2026 (%)
- Exhibit 39: Data Table on Inner ear infections - Year-over-year growth 2021-2026 (%)
- 5.6 Market opportunity by Type
- Exhibit 40: Market opportunity by Type ($ million)
6 Customer Landscape
- 6.1 Customer landscape overview
- Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
- 7.1 Geographic segmentation
- Exhibit 42: Chart on Market share by geography 2021-2026 (%)
- Exhibit 43: Data Table on Market share by geography 2021-2026 (%)
- 7.2 Geographic comparison
- Exhibit 44: Chart on Geographic comparison
- Exhibit 45: Data Table on Geographic comparison
- 7.3 North America - Market size and forecast 2021-2026
- Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
- Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
- 7.4 Europe - Market size and forecast 2021-2026
- Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
- Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
- 7.5 Asia - Market size and forecast 2021-2026
- Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
- Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
- 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
- Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- 7.7 US - Market size and forecast 2021-2026
- Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
- Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
- 7.8 Denmark - Market size and forecast 2021-2026
- Exhibit 66: Chart on Denmark - Market size and forecast 2021-2026 ($ million)
- Exhibit 67: Data Table on Denmark - Market size and forecast 2021-2026 ($ million)
- Exhibit 68: Chart on Denmark - Year-over-year growth 2021-2026 (%)
- Exhibit 69: Data Table on Denmark - Year-over-year growth 2021-2026 (%)
- 7.9 China - Market size and forecast 2021-2026
- Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
- Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
- 7.10 Canada - Market size and forecast 2021-2026
- Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
- Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
- 7.11 India - Market size and forecast 2021-2026
- Exhibit 78: Chart on India - Market size and forecast 2021-2026 ($ million)
- Exhibit 79: Data Table on India - Market size and forecast 2021-2026 ($ million)
- Exhibit 80: Chart on India - Year-over-year growth 2021-2026 (%)
- Exhibit 81: Data Table on India - Year-over-year growth 2021-2026 (%)
- 7.12 Market opportunity by geography
- Exhibit 82: Market opportunity by geography ($ million)
8 Drivers, Challenges, and Trends
- 8.1 Market drivers
- 8.2 Market challenges
- 8.3 Impact of drivers and challenges
- Exhibit 83: Impact of drivers and challenges in 2021 and 2026
- 8.4 Market trends
9 Vendor Landscape
- 9.1 Overview
- 9.2 Vendor landscape
- Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
- 9.3 Landscape disruption
- Exhibit 85: Overview on factors of disruption
- 9.4 Industry risks
- Exhibit 86: Impact of key risks on business
10 Vendor Analysis
- 10.1 Vendors covered
- Exhibit 87: Vendors covered
- 10.2 Market positioning of vendors
- Exhibit 88: Matrix on vendor position and classification
- 10.3 Akorn Inc.
- Exhibit 89: Akorn Inc. - Overview
- Exhibit 90: Akorn Inc. - Product / Service
- Exhibit 91: Akorn Inc. - Key offerings
- 10.4 F. Hoffmann La Roche Ltd.
- Exhibit 92: F. Hoffmann La Roche Ltd. - Overview
- Exhibit 93: F. Hoffmann La Roche Ltd. - Business segments
- Exhibit 94: F. Hoffmann La Roche Ltd. - Key offerings
- Exhibit 95: F. Hoffmann La Roche Ltd. - Segment focus
- 10.5 GlaxoSmithKline Plc
- Exhibit 96: GlaxoSmithKline Plc - Overview
- Exhibit 97: GlaxoSmithKline Plc - Business segments
- Exhibit 98: GlaxoSmithKline Plc - Key news
- Exhibit 99: GlaxoSmithKline Plc - Key offerings
- Exhibit 100: GlaxoSmithKline Plc - Segment focus
- 10.6 Johnson and Johnson
- Exhibit 101: Johnson and Johnson - Overview
- Exhibit 102: Johnson and Johnson - Business segments
- Exhibit 103: Johnson and Johnson - Key news
- Exhibit 104: Johnson and Johnson - Key offerings
- Exhibit 105: Johnson and Johnson - Segment focus
- 10.7 Lupin Ltd.
- Exhibit 106: Lupin Ltd. - Overview
- Exhibit 107: Lupin Ltd. - Product / Service
- Exhibit 108: Lupin Ltd. - Key news
- Exhibit 109: Lupin Ltd. - Key offerings
- 10.8 Novartis AG
- Exhibit 110: Novartis AG - Overview
- Exhibit 111: Novartis AG - Business segments
- Exhibit 112: Novartis AG - Key offerings
- Exhibit 113: Novartis AG - Segment focus
- 10.9 Otonomy Inc.
- Exhibit 114: Otonomy Inc. - Overview
- Exhibit 115: Otonomy Inc. - Product / Service
- Exhibit 116: Otonomy Inc. - Key offerings
- 10.10 Pfizer Inc.
- Exhibit 117: Pfizer Inc. - Overview
- Exhibit 118: Pfizer Inc. - Product / Service
- Exhibit 119: Pfizer Inc. - Key news
- Exhibit 120: Pfizer Inc. - Key offerings
- 10.11 Sensorion
- Exhibit 121: Sensorion - Overview
- Exhibit 122: Sensorion - Product / Service
- Exhibit 123: Sensorion - Key offerings
- 10.12 WraSer Pharmaceuticals
- Exhibit 124: WraSer Pharmaceuticals - Overview
- Exhibit 125: WraSer Pharmaceuticals - Product / Service
- Exhibit 126: WraSer Pharmaceuticals - Key offerings
11 Appendix
- 11.1 Scope of the report
- 11.2 Inclusions and exclusions checklist
- Exhibit 127: Inclusions checklist
- Exhibit 128: Exclusions checklist
- 11.3 Currency conversion rates for US$
- Exhibit 129: Currency conversion rates for US$
- 11.4 Research methodology
- Exhibit 130: Research methodology
- Exhibit 131: Validation techniques employed for market sizing
- Exhibit 132: Information sources
- 11.5 List of abbreviations
- Exhibit 133: List of abbreviations
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
Share this article